Dr. sc. Arijana Meštrović, MPharm CoDEG Eastern and Central

Dr. sc. Arijana Meštrović, MPharm
CoDEG Eastern and Central Europe representative
Sarajevo, Bosnia and Herzegovina
LET US TALK ABOUT…
• Local and global picture
• Where we want to be?
• Advanced pharmacy
• Suggestions
• Evidence
• Experience
• Budget
• Challenges
• Motivation
The Competency Development and
Evaluation Group (CoDEG) is a
collaborative network of specialist
and
academic
pharmacists,
developers,
researchers
and
practitioners.
Its aim is to undertake research and
evaluation in order to help develop
and support pharmacy practitioners
and ensure their fitness to practice at
all levels.
PHARMACEUTICAL CARE
AND PUBLIC HEALTH
COMPETENCIES
ORGANISATION AND
MANAGEMENT
COMPETENCIES
PROFESSIONAL AND
PERSONAL
COMPETENCIES
Descriptive Competency Values
Rating
Consistently
(4)
Definitions
Prevalence
Demonstrates the expected
85-100%
standard practice with very rare
lapses
Mostly
(3)
Implies standard practice with
occasional lapses
51-84%
Rarely
(2)
Much more haphazard than
“mostly”
21-50%
Never
(1)
Very rarely meets the standard
expected. No logical thought
process appears to apply
0-20%
average
4
3
2
1
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
competency (C)
poorest performance
•Monitoring drug therapy
•Use of guidelince
•Patient consultation
•Evaluation of outcomes


best performance
Drug specific issues
Provision of drug product
transnational
collaboration
• Patient
consultation
4
Difference of behavioral statements 2009 and 2010
3.8
• Monitoring
drug therapy
3.6
3.4
3.2
• Medicine
information
3
2.8
2.6
• Patient
education
2.4
2.2
2
• Evaluation of
outcomes
1.8
1.6
1.4
1.2
1
1
3
5
7
9
11
13
15
17
Behavioral statements
19
21
23
25
The greatest discrepancies among
pharmacists were found in …
0,9
0,8
0,7
0,6
0,5
0,4
0,3
0,2
0,1
0
variance
ensuring that the
prescription is legal
 prioritizing medicine
management problems
 identifying drug-drug
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
interactions
 to develop standard operating procedures

 to develop frameworks for data collection
 to provide more written information for patient safety
 to document pharmacy intervention
New services and
standard operating
procedures were
implemented in
addition to the
mandatory
documentation
contribution in the
pharmacist’s
portfolio.
clinically significant side effects
 drug related problems
 documented medical interventions
 documented medication errors
 false prescriptions

ADVANCED PHARMACY
New - visible role in health system
 Pharmaceutical care
 Medication errors
 Medication history
 Adverse reactions
 Clinical interactions
 Medical interventions
 Public health
 Individualising therapy
 Prescribers feedback

ADVANCED PHARMACY
In pharmacy
 collaboration practice
 building brand
 portfolio
 evidence based decision making
 publishing results
 tailored Education
 competency developement
 providing advanced services
 moving borders
 collecting data for reimbursement
 saving costs, increasing income